Literature DB >> 8629949

Genetic complementation between replication-defective mutants of HIV-1 and SIVagm.

T Miura1, R Shibata, A Adachi, T Kuwata, J Chen, M Jin, E Ido, M Hayami.   

Abstract

To investigate the functional complementation of essential genes for virus growth between HIV-1 and SIVagm derived from African green monkeys, we co-transfected replication-defective molecular clones containing mutations in gag, pol, env, tat or rev, and monitored transient complementation by reverse transcriptase assay (RT), cytopathic effect (CPE) and immunofluorescence assay (IFA). The following results were obtained: 1) No complementation was observed in combinations of the gag and pol mutants. 2) The rev mutant of HIV-1 was minimally complemented by other SIVagm mutants, although the rev mutant of SIVagm was significantly complemented by other HIV-1 mutants. 3) Among all combinations tested, the env mutant of HIV-1 was the most effectively complemented by SIVagm mutants. 4) CPE was mostly absent in combinations of the env mutant of SIVagm and the gag, pol, or tat mutants of HIV-1, although there were significant positive results in RT and IFA assays. These findings provided basic information about the functional compatibility of pathogenic HIV-1 and nonpathogenic SIVagm which will be useful for generating chimeras of these two viruses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8629949     DOI: 10.1007/bf01718586

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  43 in total

1.  Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.

Authors:  R Shibata; M Kawamura; H Sakai; M Hayami; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.

Authors:  N Lewis; J Williams; D Rekosh; M L Hammarskjöld
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements.

Authors:  S K Arya; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Functional comparison of transactivation by human retrovirus rev and rex genes.

Authors:  H Sakai; H Siomi; H Shida; R Shibata; T Kiyomasu; A Adachi
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  A distinct African lentivirus from Sykes' monkeys.

Authors:  V M Hirsch; G A Dapolito; S Goldstein; H McClure; P Emau; P N Fultz; M Isahakia; R Lenroot; G Myers; P R Johnson
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys.

Authors:  T Igarashi; R Shibata; F Hasebe; Y Ami; K Shinohara; T Komatsu; C Stahl-Hennig; H Petry; G Hunsmann; T Kuwata
Journal:  AIDS Res Hum Retroviruses       Date:  1994-08       Impact factor: 2.205

10.  Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses.

Authors:  L Chakrabarti; M Guyader; M Alizon; M D Daniel; R C Desrosiers; P Tiollais; P Sonigo
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.